About SurModics
SurModics is a company based in Eden Prairie (United States) founded in 1979 was acquired by GTCR in May 2024. The company has 389 employees as of September 30, 2024. SurModics has completed 2 acquisitions, including NorMedix and Vetex Medical. SurModics offers products and services including Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings. SurModics operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
- Headquarter Eden Prairie, United States
- Employees 389 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Surmodics, Inc.
-
Annual Revenue
$126.08 M (USD)-4.91as on Sep 30, 2024
-
Net Profit
-$11.54 M (USD)-651.43as on Sep 30, 2024
-
EBITDA
$6.75 M (USD)-54.33as on Sep 30, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
389
as on Sep 30, 2024
-
Investments & Acquisitions
NorMedix
& 1 more
-
Acquired by
GTCR
(May 29, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of SurModics
SurModics is a publicly listed company on the NASDAQ with ticker symbol SRDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of SurModics
SurModics offers a comprehensive portfolio of products and services, including Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings.
Device for rapid removal of peripheral arterial thrombi
System to capture and remove clots in peripheral veins
Tools for radial-to-peripheral procedures with kink resistance
Coatings for navigating tortuous anatomy in neuro and coronary areas
People of SurModics
Unlock access to complete
Sales and Marketing
10 people
Software Development Team
9 people
Senior Team
6 people
Product Management Team
5 people
Principal Team
5 people
Operations Team
5 people
Leadership Team
4 people
Finance and Accounting
3 people
Unlock access to complete
Funding Insights of SurModics
Detailed funding history for SurModics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in SurModics
SurModics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GTCR Chicago Private Equity Firm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments and firm management in Chicago.
|
Locked | Locked | Locked |
Investor details for SurModics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SurModics
SurModics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include NorMedix and Vetex Medical.
Investment portfolio details for SurModics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Catheters for venous clot management and removal are developed.
|
Locked | Locked | 2016 | Locked | |
|
Surgical medical devices are designed and developed by NorMedix.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for SurModics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SurModics
Detailed financials for SurModics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surmodics Comparisons
Peer comparison for SurModics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SurModics
SurModics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Spear Bio and Eclipse Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| Locked | Locked | Locked |
An in vitro assay platform is provided for diagnostic solutions.
|
Detailed competitors of SurModics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surmodics
Complete news archive for SurModics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SurModics
SurModics was founded in 1979.
SurModics is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
As of Sep 30, 2024, the latest employee count at SurModics is 389.
Annual revenue of SurModics is $126.08M as on Sep 30, 2024.
SurModics was founded in 1979 and is headquartered in Eden Prairie, United States. Operations focus on the biotechnology sector, where in-vitro diagnostic assays and reagents are produced for clinical applications. Immunoassays such as ELISAs are developed alongside point-of-care devices. Key products encompass antigens, antibodies, protein stabilizers, diluents, blockers, substrates, microarray slides, and TMB formulations to support diagnostic workflows.
SurModics's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
SurModics offers Pounce™ Thrombectomy System, Pounce™ Venous Thrombectomy System, Sublime™ Radial Access Platform, and Preside™ Hydrophilic Coatings.
Yes, SurModics is publicly traded on NASDAQ under the ticker symbol SRDX.
SurModics has made 2 acquisitions, including NorMedix, and Vetex Medical.
SurModics has 1 investor. Key investors include GTCR Chicago Private Equity Firm.
The ticker symbol of SurModics is SRDX on NASDAQ.